Forbes - FDA Approves Johnson & Johnson Vaccine

Plus: 6 weird ways people tried to cure the 1918 flu

On Saturday, the FDA granted an Emergency Use Authorization to Johnson & Johnson for the company’s single-shot Covid-19 vaccine, meaning it can now be given to the public. The vaccine, which uses a harmless viral vector, only requires one shot and can be stored at normal refrigerated temperatures. Johnson & Johnson says that it will have 20 million doses available by the end of March, and 100 million doses by the end of June. This is a huge win that could help turn the tide of the pandemic; 20% of U.S. adults are now vaccinated, and more will have the opportunity to get vaccines very soon. However, that doesn’t mean that we can reopen everything at once. CDC director Dr. Rochelle Wallensky has cautioned against relaxing restrictions too quickly. 

Business

The Dow soared 600 points today after the House passed President Biden’s $1.9 trillion stimulus plan. 

The President says that he is open to a lower income threshold for new stimulus checks. 

Twitter is developing new systems to tackle Covid-19 misinformation on the platform.

Science & Health

A new poll says Johnson & Johnson’s Covid-19 vaccine could help overcome vaccine hesitancy in the U.S. 

What’s the difference between a variant, a mutant and a strain of Covid-19? Here’s what you need to know. 

A recent study shows that one-third of patients who had severe Covid-19 experience symptoms of PTSD.

What Else We Are Reading

• Feds OK’d Export of Millions of N95 Masks as U.S. Workers Cried for More (Kaiser Health News)

• Why has coronavirus testing slumped in the U.S.? It’s complicated.  (The New York Times)

• The Pandemic Ruined Time (The Verge)